Correlation between type 2 diabetes mellitus remission and intrapancreatic fat deposition.
World J Clin Cases
; 12(21): 4536-4542, 2024 Jul 26.
Article
in En
| MEDLINE
| ID: mdl-39070807
ABSTRACT
BACKGROUND:
Intrapancreatic fat deposition (IPFD) exerts a significant negative impact on patients with type 2 diabetes mellitus (T2DM), accelerates disease deterioration, and may lead to impaired ß-cell quality and function.AIM:
To investigate the correlation between T2DM remission and IPFD.METHODS:
We enrolled 80 abdominally obese patients with T2DM admitted to our institution from January 2019 to October 2023, including 40 patients with weight loss-induced T2DM remission (research group) and 40 patients with short-term intensive insulin therapy-induced T2DM remission (control group). We comparatively analyzed improvements in IPFD [differential computed tomography (CT) values of the spleen and pancreas and average CT value of the pancreas]; levels of fasting blood glucose (FBG), 2-h postprandial blood glucose (2hPBG), and insulin; and homeostasis model assessment of insulin resistance (HOMA-IR) scores. Correlation analysis was performed to explore the association between T2DM remission and IPFD.RESULTS:
After treatment, the differential CT values of the spleen and pancreas, FBG, 2hPBG, and HOMA-IR in the research group were significantly lower than those before treatment and in the control group, and the average CT value of the pancreas and insulin levels were significantly higher. Correlation analysis revealed that the greater the T2DM remission, the lower the amount of IPFD.CONCLUSION:
T2DM remission and IPFD are inversely correlated.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
World J Clin Cases
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos